Works matching IS 14783223 AND DT 2022 AND VI 42 AND IP 3

Results: 26
    1
    2

    Issue Cover.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. i, doi. 10.1111/liv.15203
    By:
    • Gerussi, Alessio;
    • Verda, Damiano;
    • Bernasconi, Davide Paolo;
    • Carbone, Marco;
    • Komori, Atsumasa;
    • Abe, Masanori;
    • Inao, Mie;
    • Namisaki, Tadashi;
    • Mochida, Satoshi;
    • Yoshiji, Hitoshi;
    • Hirschfield, Gideon;
    • Lindor, Keith;
    • Pares, Albert;
    • Corpechot, Christophe;
    • Cazzagon, Nora;
    • Floreani, Annarosa;
    • Marzioni, Marco;
    • Alvaro, Domenico;
    • Vespasiani‐Gentilucci, Umberto;
    • Cristoferi, Laura
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Low cardiopulmonary fitness is associated with higher liver fat content and higher gamma‐glutamyltransferase concentrations in the general population – "The Sedentary's Liver".

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 585, doi. 10.1111/liv.15162
    By:
    • Zinterl, Ines;
    • Ittermann, Till;
    • Schipf, Sabine;
    • Gross, Stefan;
    • Anspieler, Henryke;
    • Kim, Simon;
    • Ewert, Ralf;
    • Bülow, Robin;
    • Kühn, Jens‐Peter;
    • Lerch, Markus M.;
    • Völzke, Henry;
    • Felix, Stephan Burkhard;
    • Bahls, Martin;
    • Targher, Giovanni;
    • Dörr, Marcus;
    • Markus, Marcello Ricardo Paulista
    Publication type:
    Article
    9

    Early prediction of decompensation (EPOD) score: Non‐invasive determination of cirrhosis decompensation risk.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 640, doi. 10.1111/liv.15161
    By:
    • Schneider, Annika R. P.;
    • Schneider, Carolin V.;
    • Schneider, Kai Markus;
    • Baier, Vanessa;
    • Schaper, Steffen;
    • Diedrich, Christian;
    • Coboeken, Katrin;
    • Mayer, Hannah;
    • Gu, Wenyi;
    • Trebicka, Jonel;
    • Blank, Lars M.;
    • Burghaus, Rolf;
    • Lippert, Joerg;
    • Rader, Daniel J.;
    • Thaiss, Christoph A.;
    • Schlender, Jan‐Frederik;
    • Trautwein, Christian;
    • Kuepfer, Lars
    Publication type:
    Article
    10

    Integrins as a drug target in liver fibrosis.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 507, doi. 10.1111/liv.15157
    By:
    • Rahman, Syedia R.;
    • Roper, James A.;
    • Grove, Jane I.;
    • Aithal, Guruprasad P.;
    • Pun, K. Tao;
    • Bennett, Andrew J.
    Publication type:
    Article
    11
    12
    13
    14

    Machine learning in primary biliary cholangitis: A novel approach for risk stratification.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 615, doi. 10.1111/liv.15141
    By:
    • Gerussi, Alessio;
    • Verda, Damiano;
    • Bernasconi, Davide Paolo;
    • Carbone, Marco;
    • Komori, Atsumasa;
    • Abe, Masanori;
    • Inao, Mie;
    • Namisaki, Tadashi;
    • Mochida, Satoshi;
    • Yoshiji, Hitoshi;
    • Hirschfield, Gideon;
    • Lindor, Keith;
    • Pares, Albert;
    • Corpechot, Christophe;
    • Cazzagon, Nora;
    • Floreani, Annarosa;
    • Marzioni, Marco;
    • Alvaro, Domenico;
    • Vespasiani‐Gentilucci, Umberto;
    • Cristoferi, Laura
    Publication type:
    Article
    15
    16
    17

    Hepatocellular carcinoma after treatment cessation in non‐cirrhotic HBeAg‐negative chronic hepatitis B: A multicentre cohort study.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 541, doi. 10.1111/liv.15128
    By:
    • Papatheodoridi, Margarita;
    • Su, Tung‐Hung;
    • Hadziyannis, Emilia;
    • Liao, Chun‐Hsun;
    • Orfanidou, Αfroditi;
    • Yang, Hung‐Chi;
    • Zachou, Kalliopi;
    • Liu, Chun‐Jen;
    • Kourikou, Anastasia;
    • Gatselis, Nikolaos;
    • Manolakopoulos, Spilios;
    • Dalekos, George;
    • Kao, Jia‐Horng;
    • Hadziyannis, Stephanos;
    • Papatheodoridis, George V.
    Publication type:
    Article
    18
    19
    20

    Issue Information.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 483, doi. 10.1111/liv.14953
    Publication type:
    Article
    21
    22
    23
    24

    Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 607, doi. 10.1111/liv.15121
    By:
    • Efe, Cumali;
    • Lammert, Craig;
    • Taşçılar, Koray;
    • Dhanasekaran, Renumathy;
    • Ebik, Berat;
    • Higuera‐de la Tijera, Fatima;
    • Calışkan, Ali R.;
    • Peralta, Mirta;
    • Gerussi, Alessio;
    • Massoumi, Hatef;
    • Catana, Andreea M.;
    • Purnak, Tugrul;
    • Rigamonti, Cristina;
    • Aldana, Andres J. G.;
    • Khakoo, Nidah;
    • Nazal, Leyla;
    • Frager, Shalom;
    • Demir, Nurhan;
    • Irak, Kader;
    • Melekoğlu‐Ellik, Zeynep
    Publication type:
    Article
    25
    26

    Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India.

    Published in:
    Liver International, 2022, v. 42, n. 3, p. 532, doi. 10.1111/liv.15112
    By:
    • Markby, Jessica;
    • Gupta, Ekta;
    • Soni, Divya;
    • Sarin, Sanjay;
    • Murya, Mugil;
    • Katapur, Preetishirin;
    • Tewatia, Navneet;
    • Ramachandran, Babu Entoor;
    • Ruiz, Ryan Jose;
    • Gaeddert, Mary;
    • Tyshkovskiy, Alexander;
    • Adee, Madeline;
    • Chhatwal, Jagpreet;
    • Miglani, Sundeep;
    • Easterbrook, Philippa;
    • Sarin, Shiv K.;
    • Shilton, Sonjelle
    Publication type:
    Article